Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
3.180
-0.290 (-8.36%)
At close: Apr 1, 2025, 4:00 PM
3.374
+0.194 (6.11%)
After-hours: Apr 1, 2025, 5:02 PM EDT

Alterity Therapeutics Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2015
Other Revenue
3.724.023.925.124.34-
Upgrade
Revenue
3.724.023.925.124.34-
Upgrade
Revenue Growth (YoY)
8.55%2.63%-23.56%18.06%--
Upgrade
Cost of Revenue
0.180.210.290.360.360.35
Upgrade
Gross Profit
3.543.83.634.763.98-0.35
Upgrade
Selling, General & Admin
5.694.765.065.516.943.45
Upgrade
Research & Development
1818.6413.214.7512.2810.1
Upgrade
Other Operating Expenses
0.060.010.03000.04
Upgrade
Operating Expenses
24.0723.4118.2720.2619.1613.58
Upgrade
Operating Income
-20.53-19.61-14.64-15.5-15.18-13.93
Upgrade
Interest & Investment Income
0.260.270.0200.020.02
Upgrade
Currency Exchange Gain (Loss)
0.520.260.922.72-0.30.33
Upgrade
EBT Excluding Unusual Items
-19.74-19.08-13.7-12.78-15.45-13.58
Upgrade
Other Unusual Items
----0.150.12
Upgrade
Pretax Income
-19.74-19.08-13.7-12.78-15.31-13.46
Upgrade
Income Tax Expense
0.050.050.10.07--
Upgrade
Net Income
-19.79-19.12-13.81-12.85-15.31-13.46
Upgrade
Net Income to Common
-19.79-19.12-13.81-12.85-15.31-13.46
Upgrade
Shares Outstanding (Basic)
5,0543,6492,4282,4061,697895
Upgrade
Shares Outstanding (Diluted)
5,0543,6492,4282,4061,697895
Upgrade
Shares Change (YoY)
104.33%50.29%0.91%41.79%89.62%45.32%
Upgrade
EPS (Basic)
-0.00-0.01-0.01-0.01-0.01-0.02
Upgrade
EPS (Diluted)
-0.00-0.01-0.01-0.01-0.01-0.02
Upgrade
Free Cash Flow
-16.47-12.61-20.04-12.43-17.34-9.45
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.01-0.01-0.01-0.01
Upgrade
Gross Margin
95.14%94.67%92.72%92.88%91.70%-
Upgrade
Operating Margin
-551.15%-487.82%-373.72%-302.56%-349.77%-
Upgrade
Profit Margin
-531.34%-475.79%-352.54%-250.75%-352.78%-
Upgrade
Free Cash Flow Margin
-442.22%-313.78%-511.78%-242.54%-399.59%-
Upgrade
EBITDA
-20.49-19.57-14.6-15.48-15.16-13.9
Upgrade
D&A For EBITDA
0.030.040.040.020.020.03
Upgrade
EBIT
-20.53-19.61-14.64-15.5-15.18-13.93
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q